Rebirth 08: Rise from copycat phones

Chapter 654 The Top Circle of the Global Village
In an African country, a super-rich man from Eastern Europe arrived quietly and completed his final physical examination at a local medical institution whose facilities clearly exceeded the standards of the country.

Several days later, this super-rich man began taking the very special drug ARE78 under strict medical supervision.

"This is a personalized medicine for you, developed based on your individual DNA. It only works for you; it will be ineffective and even harmful to others!"

"Initially, take one pill a day for a week. Do not leave during this week. We need to conduct a comprehensive check on your physical condition to prevent side effects. If significant side effects occur and do not improve, we will need to stop taking the medication!"

"If everything goes well, you can leave in a week, taking with you your medication supply for the next year. Take one pill every three days for six months, and then one pill a week thereafter. You also need to have your medical team send us a medical report every week!"
"We need to continuously monitor your medication and physical condition!"

The super-rich man nodded slightly, then took a plain-looking capsule and a glass of water, which he then swallowed with water.

Similar situations have occurred in many other parts of the world.

At a renowned top-tier private hospital in the United States, several ultra-wealthy individuals in their seventies and eighties underwent comprehensive medical examinations, received final approval to use the medication ARE78, and then began taking it.

The same situation has occurred in Brazil, ASEAN, Europe, and other places.

Some of the world's elderly super-rich individuals, after undergoing medical reviews and confirming that their physical condition met the requirements for medication, were subsequently scheduled to receive the drugs.

The medication standards for each individual are also highly standardized: $13 million per person per year, payable only in cash or cash equivalents. This fee must be paid before the medical review is completed and medication is administered. Furthermore, this fee is non-refundable if side effects occur during the trial and medication needs to be discontinued.

If no side effects occur during the drug trial, then the staff of Galaxy Life will reappear.

"Mr. Novak, congratulations on passing the trial period without any side effects. You can now return to taking the medication as scheduled. With a healthy diet and exercise, I believe you will be able to recover at least fifteen years of physical function!"

Novak smiled as he looked at the staff members from the Galactic Life system in front of him: "I also hope that can be the case. I want to thank you for the medicine, and even more so for the hard work of your research team. Without you, my friends and I would not have had this opportunity!"

"Returning to youth is something I've always longed for... You young people can hardly imagine how much we old folks yearn for a healthy body!"

The middle-aged man leading the Galactic Life group said, "The expectations of our sponsors and clients are what we strive for!"

"The success of the ARE78 project is inseparable from the generous funding of donors like Mr. Novak. Although the ARE78 project has achieved initial success, there are still many shortcomings. Our Galactic Life Sciences research team is continuing its research and working hard to develop the second generation of ARE78!"

"And Mr. Novak, a successful entrepreneur like you should also know very well that technological research and development is a very expensive undertaking, especially in the field of life and health, where the costs are even greater!"

"In order to better develop the second-generation drugs of the ARE78 project, and also to carry out more anti-aging technologies and research on other cancers or fatal diseases, we have started a new round of fundraising!"

Novak glanced at the galactic lifeform staff in front of him for a few seconds before asking, "Are there any funding restrictions?"

The middle-aged man from Galaxy Life said, "In principle, there isn't one. After all, this is a gratuitous donation. We welcome donations from anyone with the ability and ideals to the field of human life and health. Even if the other party only gives one million or ten million US dollars, we will sincerely thank them!"

"However, given the high development costs and extremely limited production capacity of the second-generation ARE78 drug, I have heard that the board of directors is considering giving priority to philanthropists who have provided more than one hundred million US dollars in funding for the future second-generation ARE78 drug!"

Novak said, "I understand!"

"Before I leave, one hundred million US dollars will appear in the account you designate!"

The middle-aged man from Galactic Life immediately smiled broadly: "Thank you, Mr. Novak, for your generous donation to the science of human life and health. I won't disturb your rest any longer!"

Similarly, similar situations have occurred in many places!
The super-rich who passed the drug trial generously donated money, some because they trusted the drug or felt that a few hundred million dollars didn't matter, and transferred the money on the spot.

Some said they needed to consider it, and would only pay after the ARE78 medication they were currently taking had a certain effect and they saw real results.

The secret staff of Galactic Life travel around the world, contacting donors globally, arranging checkups, medication, collecting regular annual fees, and prompting them to initiate the next round of funding.

Of course, the $100 million funding threshold mentioned by Galaxy Life staff is just a priority level. It doesn't mean that donating tens of millions of dollars is not acceptable. It just means that if the amount donated is small, the priority will be lower. In short, the more money donated, the higher the priority will be.

If anything good is produced, it will be given priority to these top-ranked donors.

Galaxy Life's funding service system is all about money... The richest patrons are the bosses!
After all, Galaxy Life, this secretive company, was, to some extent, founded by a group of super-rich individuals who funded the establishment of it in order to obtain opportunities for anti-aging and life extension.

But it's not like you can't do it without paying... Actually, it's possible, but you'll have to wait a long time.

For example, the ARE78 project will eventually be commercialized... When the cost drops significantly to a level that ordinary people can afford, then even ordinary people will be able to buy and use it.

It's just a matter of time!

In the first phase of the ARE78 project, it wasn't only donors who donated hundreds of millions of dollars who got the opportunity to receive the medication; in fact, some donors who only donated tens of millions of dollars also got the chance.

But you need to buy a ticket on the side... and the supplementary ticket is more expensive!

For example, if a donor who previously donated $50 million experiences the effect of regaining youth after taking the medication for the first year, a staff member from Galaxy Life will subtly remind them: "Sir, your donation account has insufficient funds... Please replenish $150 million to ensure that the donation account has more than $200 million so that we can provide you with better services."

The initial funding priority threshold for Galaxy Life was one hundred million US dollars. However, due to a lack of results over a long period, the standard was lowered in order to obtain more funding, and now tens of millions of US dollars can also qualify for funding.

If more than $100 million is donated before the drug is successfully developed, then priority access to its use will be granted...

If only tens of millions of dollars were previously funded, and now that the development has been completed, if the other party still wants to obtain priority, then the remaining 200 million dollars in funding must be paid.

Because this kind of funding is actually a form of venture capital.

When there are no results to show for it, giving a hundred million dollars is a significant gesture.

Now that we have achieved results, those who didn't donate enough money before will have to pay a higher price to have them.

As for those who haven't received funding before... I'm sorry, they don't even know about the ARE78 project, or even the existence of Galaxy Life, this special company.

The threshold for funding Galaxy Life has always been very high... not only in terms of funding, but also in terms of other conditions.

It's not like you can get in just by having tens of millions or a hundred or two hundred million dollars.

Money is just the most basic requirement; there are a whole host of hidden conditions.

For example, the most basic and core condition is that if you want to fund galactic life, you must first know about its existence, then be able to contact it, and only then can you talk about so-called funding.

Wanting to know about and contact Galaxy Life... is naturally no secret to the top conglomerates on Earth. When Galaxy Life was first established, it was Xu Shenxue who spearheaded the project, and they all contributed their money.

A group of super-rich people are afraid of death and want to develop anti-aging technology or even extend their lifespan!
Within the secondary conglomerate circle, some are introduced by top-tier conglomerates, while others are simply approached by members of Galactic Life on their own.

The two circles mentioned above don't need to put in much effort; they can naturally learn about the existence of galactic life and make contact. As for whether to provide financial assistance or donations to galactic life, that's a matter of personal judgment.

Beyond them, it's not so easy for ordinary wealthy people to learn about galactic life, and it's even more difficult to make contact with it.

Galactic life forms are also very low-key, even secretive... To date, the public still knows nothing about their existence.

Well, you can't know about the existence of life in the Milky Way unless you reach a certain level!
Participating in the Galactic Life Project is, to some extent, a symbol of status and wealth...

------

Galaxy Life's ARE78 project has launched its first batch of commercial applications, but the scale is not large, with only more than 300 super-rich individuals or their family members participating.

The main purpose of this application is to target the sponsors and their immediate family members, and it is not open to the outside world.

At the same time, many super-rich individuals are still quite cautious. Although they feel that the AR78 project is already quite good, there may still be some uncertainties. Many elderly super-rich individuals who are still in good physical condition do not intend to participate in the project immediately, but want to wait and see.

Currently, those involved are mostly older, super-rich individuals and their families who have an urgent need to restore their physical functions and are unwilling to wait any longer.

Meanwhile, Galaxy Life also wanted to control the project's progress and reduce risks... After all, this time the person taking the drug was not an experimental subject, but a funder, and they couldn't afford any serious risks.

Therefore, galactic life forms are behaving with considerable caution!
Even Xu Shenxue, the controller of Galactic Life, was extremely cautious... The first batch of commercial applications of the ARE78 project did not include those close to him, especially the proposed management and scientific groups. Xu Shenxue had long planned to supply ARE78 drugs to his older scientists, but to mitigate risks and continuously reduce the cost of ARE78 drugs, he planned to wait a few more years, ideally until the second-generation ARE78 drug was successfully developed.

The first-generation ARE78 drug still had some side effects, so he was looking forward to the emergence of the second-generation ARE78 drug.

At the same time, we hope that the cost will be reduced to a certain level. The current cost of ARE78 is still too high. Not counting R&D expenses and other additional costs, the manufacturing cost alone is as high as millions of US dollars every year.

While the ARE78 project was experiencing some turbulence within the global conglomerate circle, the outside world was completely unaware of it!

It's impossible to make this public right now... After all, if ordinary people knew that these super-rich people had developed anti-aging drugs to restore youth, and that these drugs were too expensive to be widely available, then unnecessary trouble would arise.

This matter is too sensitive to be made public anytime soon!
However, the public commercialization of the ARE78 project is inevitable in the future... If the cost drops further and becomes affordable for ordinary high-income groups, the ARE78 project may be handed over to several white-glove companies under Galaxy Life for commercial operation.

But now, it's still too early!
In addition to the ARE78 project, Xu Shenxue has recently made significant progress on another project.

Galaxy Life's Fifth Research Institute has made a major technological breakthrough in reverse engineering of the drug Xeloda... Although they still haven't fully understood the core pharmacology of Xeloda, they have successfully replicated another broad-spectrum anticancer drug by imitating Xeloda's existing technological approach.

This new broad-spectrum anticancer drug has had its safety and efficacy largely confirmed after three phases of secret clinical trials.

Moreover, although the treatment scope of this drug overlaps to some extent with that of Xelocta, the differences are significant!
Fang Yulin, CEO of Galaxy Bio and a member of the board of directors of Galaxy Life, reported to Xu Shenxue: "The broad-spectrum anti-cancer drug successfully developed by the Fifth Research Institute is proposed to be named 'Entecene' for commercialization."

"Based on previous clinical trials, Entecavir's indications are mainly focused on squamous cell carcinoma, and it has a very good therapeutic effect on almost all known squamous cell carcinomas. In addition, it also has a certain therapeutic effect on some types of lymphomas, and at the same time, it has a certain therapeutic effect on some adenocarcinomas!"

"There is some overlap with our existing Xeloka in the fields of adenocarcinoma and lymphoma, but the overlap is not significant. However, its core treatment effect on squamous cell carcinoma is something that Xeloka does not have!"

As the first broad-spectrum anticancer drug, Xeloda is not effective for all types of cancer. It is most effective for adenocarcinoma, showing good efficacy against almost all types of adenocarcinoma. However, its effectiveness varies for other types of cancer, such as squamous cell carcinoma and lymphoma; it is effective for some but not for others.

There are many types of cancer; hundreds of types have been classified in human medicine.

Currently, Xeloda only has twenty-three main indications... but these twenty-three indications cover the major types of cancer in humans, such as lung cancer and liver cancer, which is why its sales volume is so high.

In the early days, there were only sixteen indications. Then, through clinical trials, the range of indications was expanded, and currently, twenty-three indications have been finalized.

However, the medical community, especially some research hospitals with stronger technical capabilities, also organize drug treatments for cancer patients who are not eligible for the treatment, but the results are not uniform. Some have good results, some have poor results, and some have no results.

While hyroxen is quite good, it cannot cure all cancers!

This is also why Galactic Life continues to study Herokhda, attempting to replicate its success and then develop more broad-spectrum anti-cancer drugs.

What is the mission of Galactic Life? Anti-aging and lifespan extension…

Various diseases, especially cancers, are among the biggest killers of people's lives, and many of Galaxy Life's benefactors are threatened by cancer.

Therefore, in addition to ongoing research in anti-aging drugs and life extension, anti-cancer research has long been a major research area for Galaxy Life.

You have to survive before you can talk about anti-aging and extending your lifespan!

Now, after years of reverse engineering, the Fifth Research Institute of Galactic Life has finally produced the corresponding results.

A new broad-spectrum anticancer drug has been developed!

"There are currently nine confirmed indications for Entecavir, and eight more indications require further confirmation and testing!"

"We believe that Entecavir is ready to proceed to the next stage of public clinical trials!"

Looking at the report, Xu Shenxue was also very interested in this Entecine: "Now that it's been made, let's commercialize it. Let your Galaxy Creatures handle this!"

Huaxia Yinhe Biotechnology Group is a relatively complex pharmaceutical company. It has a core subsidiary called "Huaxia Yinhe Pharmaceutical", which is responsible for the research and development and production of various drugs; Yinhe Precision, which is responsible for the research and development and production of medical devices and consumables; and Yinhe Technology, which is mainly responsible for the research and development and application of medical artificial intelligence.

It also owns more than ten small and medium-sized pharmaceutical companies overseas that it has acquired in succession.

Huaxia Yinhe Biotechnology also has sufficient funds and resources to carry out subsequent clinical trials and market launch of Entecavir.

After all, although Entecane was developed at the Fifth Research Institute of Galactic Life... just hearing the name 'Fifth Research Institute' tells you it's not exactly legitimate... its research and clinical trial data are basically unacceptable to medical institutions in various countries!

You conducted your research and experiments secretly; heaven knows how you did it, or whether you falsified anything.

Therefore, the clinical data from Galaxy Life can only be used for internal research and reference, and cannot be made public.

If Entecavir is to be commercialized, it needs to be taken over by a white-glove company like Galaxy Bio-Group, which will then conduct legal and compliant clinical trials in major medical markets in a step-by-step manner!
However, judging from the progress of Silokda's clinical trials back then, as long as Entecavir doesn't encounter any major problems, its clinical trial progress will be very fast... because cancer patients with countless indications are waiting for it to save their lives.

What happened to Hirokda back then will most likely be repeated on Enteken!

So, shortly after the Lantern Festival, Galaxy Bio-Group, which has always kept a low profile, held a press conference.

At the press conference, Fang Yulin, CEO of Galaxy Bio-Pharmaceutical Group, revealed for the first time to the outside world that the technological development of a brand-new broad-spectrum anti-cancer drug has achieved a breakthrough.

"Building on the successful technological path of Xeloda, our team of scientists under Galaxy Bio has overcome numerous obstacles and successfully developed a second broad-spectrum anticancer drug: Entecavir!"

"In our series of research and development and animal experiments, Entecavir has shown great potential. In the early animal experiments, we have preliminarily determined that Entecavir is effective against nine types of cancer!"

"We will begin clinical trials soon!"

The press conference held by Galaxy Biotech Group has once again caused a stir in the medical community... because this is the second broad-spectrum anti-cancer drug.

The emergence of the second broad-spectrum anticancer drug means that the appearance of Xelocta is neither purely accidental nor unique.

Its technical approach can be replicated.

This could lead to the continued breakthroughs in treating more types of cancer, and even the expansion of this technological approach to the treatment of other diseases.

The market reacted quickly to the launch of Entecavir, even though it had only just been announced and had not yet begun formal legal clinical trials in major countries...

However, the company that announced this news was not an ordinary pharmaceutical company, but Galaxy Bio-Pharmaceutical Group... It is the world's number one pharmaceutical company and the leader in the field of anti-cancer drugs.

Companies of this caliber wouldn't hold a press conference to announce their news without a high degree of certainty.

The fact that Galaxy Bio-Group dares to say this means that they are extremely confident.

As a result, the market reacted quickly... On that day, the stock prices of many pharmaceutical companies fell to varying degrees.

Many pharmaceutical companies also have businesses dealing in anti-cancer drugs, and quite large ones at that... While Xeloda is impressive, it cannot cure all cancers.

Of the more than 300 types of cancer, only about 20 are indicated for treatment. The remaining 300-plus types of cancer still require other anti-cancer drugs, surgery, chemotherapy, and other methods for treatment.

Now, with the emergence of GalaxyBio's Entecavir, it means that many more types of cancer will be conquered in the future... This also means that the market for traditional anticancer drugs and other technologies for these indications will disappear.

This has led to a decline in the stock prices of many pharmaceutical companies.

When these pharmaceutical companies' stock prices fell, a large number of cancer patients, whose cancers were not indicated for Xeloda, once again saw hope... a hope for survival!

They hope that the newly developed indications for Entecavir include the type of cancer they have.

For a time, a large number of cancer patients around the world were closely following the clinical trial of Entekorn and were using their own influence and voice to call for Entekorn to start clinical trials as soon as possible.

People seemed to be transported back to the scene many years ago when the hyrodactyl was first introduced... Back then, cancer patients around the world were just as frantic!
Drug regulatory agencies in many countries immediately extended invitations to Galaxy Biotech to conduct clinical trials there, promising to provide necessary assistance.

(End of this chapter)